Edna Maneval
Chief Tech/Sci/R&D Officer chez ORIC PHARMACEUTICALS, INC.
Profil
Edna Chow Maneval is currently the Senior Vice President-Clinical Development at Oric Pharmaceuticals, Inc. She previously held positions as Vice President-Clinical Development at Aragon Pharmaceuticals, Inc., Seragon Pharmaceuticals, Inc., and.
Senior Vice President-Clinical Development at Ignyta, Inc. Dr. Maneval obtained a doctorate degree from the University of Southern California.
Postes actifs de Edna Maneval
| Sociétés | Poste | Début |
|---|---|---|
| ORIC PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/03/2019 |
Anciens postes connus de Edna Maneval
| Sociétés | Poste | Fin |
|---|---|---|
| IGNYTA INC | Corporate Officer/Principal | 01/01/2018 |
Seragon Pharmaceuticals, Inc.
 Seragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Seragon Pharmaceuticals, Inc. developes biopharmaceutical products for the treatment of estrogen receptor dependent breast cancer. The company was founded in 2013 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01/01/2014 |
Aragon Pharmaceuticals, Inc.
 Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aragon Pharmaceuticals, Inc. develops biopharmaceutical products, It offers a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers. The company was founded by Charles L. Sawyers and Michael Jung on May 1, 2009 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01/01/2013 |
Formation de Edna Maneval
| University of Southern California | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ORIC PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Aragon Pharmaceuticals, Inc.
Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aragon Pharmaceuticals, Inc. develops biopharmaceutical products, It offers a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers. The company was founded by Charles L. Sawyers and Michael Jung on May 1, 2009 and is headquartered in San Diego, CA. | Health Technology |
Seragon Pharmaceuticals, Inc.
Seragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Seragon Pharmaceuticals, Inc. developes biopharmaceutical products for the treatment of estrogen receptor dependent breast cancer. The company was founded in 2013 and is headquartered in San Diego, CA. | Health Technology |
Ignyta, Inc.
 Ignyta, Inc. BiotechnologyHealth Technology Ignyta, Inc. operates as a medicine biotechnology company. The firm engages in the discovering, acquiring, developing and commercializing targeted new drugs for cancer patients. The company was founded by Jonathan E. Lim on September 13, 2011 and is headquartered in South San Francisco, CA. | Health Technology |
